List of Tables
    Table 1. Tumor Necrosis Factor Receptor Superfamily Member 18 CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
    Table 2. Tumor Necrosis Factor Receptor Superfamily Member 18 Market Trends
    Table 3. Tumor Necrosis Factor Receptor Superfamily Member 18 Market Drivers
    Table 4. Tumor Necrosis Factor Receptor Superfamily Member 18 Market Challenges
    Table 5. Tumor Necrosis Factor Receptor Superfamily Member 18 Market Restraints
    Table 6. Global Tumor Necrosis Factor Receptor Superfamily Member 18 Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Tumor Necrosis Factor Receptor Superfamily Member 18 Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Tumor Necrosis Factor Receptor Superfamily Member 18 Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Tumor Necrosis Factor Receptor Superfamily Member 18 Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Tumor Necrosis Factor Receptor Superfamily Member 18 Manufacturers in Global Market, Ranking by Revenue (2021)
    Table 11. Global Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue by Manufacturer, (US$ Million), 2017-2022
    Table 12. Global Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue Share by Manufacturer, 2017-2022
    Table 13. Global Tumor Necrosis Factor Receptor Superfamily Member 18 Sales by Manufacturer, (K Pcs), 2017-2022
    Table 14. Global Tumor Necrosis Factor Receptor Superfamily Member 18 Sales Share by Manufacturer, 2017-2022
    Table 15. Global Tumor Necrosis Factor Receptor Superfamily Member 18 Price by Manufacturer (2017-2022) & (USD/Pcs)
    Table 16. Global Tumor Necrosis Factor Receptor Superfamily Member 18 Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 17. Global Tumor Necrosis Factor Receptor Superfamily Member 18 by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tumor Necrosis Factor Receptor Superfamily Member 18 as of 2021)
    Table 18. Top Players of Tumor Necrosis Factor Receptor Superfamily Member 18 in Global Market, Headquarters and Distribution of Producing Region
    Table 19. Manufacturers Tumor Necrosis Factor Receptor Superfamily Member 18 Product Type
    Table 20. Date of International Manufacturers Enter into Tumor Necrosis Factor Receptor Superfamily Member 18 Market
    Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 22. Top Tumor Necrosis Factor Receptor Superfamily Member 18 Players in United States Market, Ranking by Revenue (2021)
    Table 23. United States Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 24. United States Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue Share by Players, 2020, 2021 & 2022
    Table 25. United States Tumor Necrosis Factor Receptor Superfamily Member 18 Sales by Players, (K Pcs), 2020, 2021 & 2022
    Table 26. United States Tumor Necrosis Factor Receptor Superfamily Member 18 Sales Share by Players, 2020, 2021 & 2022
    Table 27. Global Tumor Necrosis Factor Receptor Superfamily Member 18 Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 28. Global Tumor Necrosis Factor Receptor Superfamily Member 18 Sales in Volume by Region (2017-2022) & (K Pcs)
    Table 29. Global Tumor Necrosis Factor Receptor Superfamily Member 18 Sales in Volume Forecast by Region (2023-2028) & (K Pcs)
    Table 30. Global Tumor Necrosis Factor Receptor Superfamily Member 18 Sales in Value by Region (2017-2022) & (US$ Million)
    Table 31. Global Tumor Necrosis Factor Receptor Superfamily Member 18 Sales in Value Forecast by Region (2023-2028) & (US$ Million)
    Table 32. North America Tumor Necrosis Factor Receptor Superfamily Member 18 Sales in Volume by Country (2017-2028) & (K Pcs)
    Table 33. North America Tumor Necrosis Factor Receptor Superfamily Member 18 Sales in Value by Country (2017-2028) & (US$ Million)
    Table 34. Asia Pacific Tumor Necrosis Factor Receptor Superfamily Member 18 Sales in Volume by Region (2017-2028) & (K Pcs)
    Table 35. Asia Pacific Tumor Necrosis Factor Receptor Superfamily Member 18 Sales in Value by Region (2017-2028) & (US$ Million)
    Table 36. Europe Tumor Necrosis Factor Receptor Superfamily Member 18 Sales in Volume by Country (2017-2028) & (K Pcs)
    Table 37. Europe Tumor Necrosis Factor Receptor Superfamily Member 18 Sales in Value by Country (2017-2028) & (US$ Million)
    Table 38. Latin America Tumor Necrosis Factor Receptor Superfamily Member 18 Sales in Volume by Country (2017-2028) & (K Pcs)
    Table 39. Latin Americaa Tumor Necrosis Factor Receptor Superfamily Member 18 Sales in Value by Country (2017-2028) & (US$ Million)
    Table 40. Middle East and Africa Tumor Necrosis Factor Receptor Superfamily Member 18 Sales in Volume by Country (2017-2028) & (K Pcs)
    Table 41. Middle East and Africa Tumor Necrosis Factor Receptor Superfamily Member 18 Sales in Value by Country (2017-2028) & (US$ Million)
    Table 42. Ablynx NV Corporation Information
    Table 43. Ablynx NV Description and Business Overview
    Table 44. Ablynx NV Tumor Necrosis Factor Receptor Superfamily Member 18 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 45. Ablynx NV Tumor Necrosis Factor Receptor Superfamily Member 18 Product
    Table 46. Ablynx NV Recent Development
    Table 47. Amgen Inc Corporation Information
    Table 48. Amgen Inc Description and Business Overview
    Table 49. Amgen Inc Tumor Necrosis Factor Receptor Superfamily Member 18 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 50. Amgen Inc Product
    Table 51. Amgen Inc Recent Development
    Table 52. Apogenix GmbH Corporation Information
    Table 53. Apogenix GmbH Description and Business Overview
    Table 54. Apogenix GmbH Tumor Necrosis Factor Receptor Superfamily Member 18 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 55. Apogenix GmbH Product
    Table 56. Apogenix GmbH Recent Development
    Table 57. Bristol-Myers Squibb Company Corporation Information
    Table 58. Bristol-Myers Squibb Company Description and Business Overview
    Table 59. Bristol-Myers Squibb Company Tumor Necrosis Factor Receptor Superfamily Member 18 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 60. Bristol-Myers Squibb Company Product
    Table 61. Bristol-Myers Squibb Company Recent Development
    Table 62. Five Prime Therapeutics Inc Corporation Information
    Table 63. Five Prime Therapeutics Inc Description and Business Overview
    Table 64. Five Prime Therapeutics Inc Tumor Necrosis Factor Receptor Superfamily Member 18 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 65. Five Prime Therapeutics Inc Product
    Table 66. Five Prime Therapeutics Inc Recent Development
    Table 67. Incyte Corp Corporation Information
    Table 68. Incyte Corp Description and Business Overview
    Table 69. Incyte Corp Tumor Necrosis Factor Receptor Superfamily Member 18 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 70. Incyte Corp Product
    Table 71. Incyte Corp Recent Development
    Table 72. MedImmune LLC Corporation Information
    Table 73. MedImmune LLC Description and Business Overview
    Table 74. MedImmune LLC Tumor Necrosis Factor Receptor Superfamily Member 18 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 75. MedImmune LLC Product
    Table 76. MedImmune LLC Recent Development
    Table 77. Merck & Co Inc Corporation Information
    Table 78. Merck & Co Inc Description and Business Overview
    Table 79. Merck & Co Inc Tumor Necrosis Factor Receptor Superfamily Member 18 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 80. Merck & Co Inc Product
    Table 81. Merck & Co Inc Recent Development
    Table 82. Novartis AG Corporation Information
    Table 83. Novartis AG Description and Business Overview
    Table 84. Novartis AG Tumor Necrosis Factor Receptor Superfamily Member 18 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 85. Novartis AG Product
    Table 86. Novartis AG Recent Development
    Table 87. OncoMed Pharmaceuticals Inc Corporation Information
    Table 88. OncoMed Pharmaceuticals Inc Description and Business Overview
    Table 89. OncoMed Pharmaceuticals Inc Tumor Necrosis Factor Receptor Superfamily Member 18 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 90. OncoMed Pharmaceuticals Inc Product
    Table 91. OncoMed Pharmaceuticals Inc Recent Development
    Table 92. Regeneron Pharmaceuticals Inc Corporation Information
    Table 93. Regeneron Pharmaceuticals Inc Description and Business Overview
    Table 94. Regeneron Pharmaceuticals Inc Tumor Necrosis Factor Receptor Superfamily Member 18 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 95. Regeneron Pharmaceuticals Inc Product
    Table 96. Regeneron Pharmaceuticals Inc Recent Development
    Table 97. Key Raw Materials Lists
    Table 98. Raw Materials Key Suppliers Lists
    Table 99. Tumor Necrosis Factor Receptor Superfamily Member 18 Customers List
    Table 100. Tumor Necrosis Factor Receptor Superfamily Member 18 Distributors List
    Table 101. Research Programs/Design for This Report
    Table 102. Key Data Information from Secondary Sources
    Table 103. Key Data Information from Primary Sources
List of Figures
    Figure 1. Tumor Necrosis Factor Receptor Superfamily Member 18 Product Picture
    Figure 2. Global Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Tumor Necrosis Factor Receptor Superfamily Member 18 Market Size 2017-2028 (US$ Million)
    Figure 4. Global Tumor Necrosis Factor Receptor Superfamily Member 18 Sales 2017-2028 (K Pcs)
    Figure 5. United States Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 6. United States Tumor Necrosis Factor Receptor Superfamily Member 18 Market Size 2017-2028 (US$ Million)
    Figure 7. United States Tumor Necrosis Factor Receptor Superfamily Member 18 Sales 2017-2028 (K Pcs)
    Figure 8. United States Tumor Necrosis Factor Receptor Superfamily Member 18 Market Share in Global, in Value (US$ Million) 2017-2028
    Figure 9. United States Tumor Necrosis Factor Receptor Superfamily Member 18 Market Share in Global, in Volume (K Pcs) 2017-2028
    Figure 10. Tumor Necrosis Factor Receptor Superfamily Member 18 Report Years Considered
    Figure 11. Product Picture of AMG-228
    Figure 12. Product Picture of BMS-986156
    Figure 13. Product Picture of FPA-154
    Figure 14. Product Picture of GWN-323
    Figure 15. Product Picture of INCAGN-1876
    Figure 16. Product Picture of Others
    Figure 17. Global Tumor Necrosis Factor Receptor Superfamily Member 18 Market Share by Type in 2022 & 2028
    Figure 18. Global Tumor Necrosis Factor Receptor Superfamily Member 18 Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 19. Global Tumor Necrosis Factor Receptor Superfamily Member 18 Sales Market Share in Value by Type (2017-2028)
    Figure 20. Global Tumor Necrosis Factor Receptor Superfamily Member 18 Sales by Type (2017-2028) & (K Pcs)
    Figure 21. Global Tumor Necrosis Factor Receptor Superfamily Member 18 Sales Market Share in Volume by Type (2017-2028)
    Figure 22. Global Tumor Necrosis Factor Receptor Superfamily Member 18 Price by Type (2017-2028) & (USD/Pcs)
    Figure 23. United States Tumor Necrosis Factor Receptor Superfamily Member 18 Market Share by Type in 2022 & 2028
    Figure 24. United States Tumor Necrosis Factor Receptor Superfamily Member 18 Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 25. United States Tumor Necrosis Factor Receptor Superfamily Member 18 Sales Market Share in Value by Type (2017-2028)
    Figure 26. United States Tumor Necrosis Factor Receptor Superfamily Member 18 Sales by Type (2017-2028) & (K Pcs)
    Figure 27. United States Tumor Necrosis Factor Receptor Superfamily Member 18 Sales Market Share in Volume by Type (2017-2028)
    Figure 28. United States Tumor Necrosis Factor Receptor Superfamily Member 18 Price by Type (2017-2028) & (USD/Pcs)
    Figure 29. Product Picture of Melanoma
    Figure 30. Product Picture of Non-Small Cell Lung Cancer
    Figure 31. Product Picture of Gastric Cancer
    Figure 32. Product Picture of Blood Cancer
    Figure 33. Product Picture of Others
    Figure 34. Global Tumor Necrosis Factor Receptor Superfamily Member 18 Market Share by Application in 2022 & 2028
    Figure 35. Global Tumor Necrosis Factor Receptor Superfamily Member 18 Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 36. Global Tumor Necrosis Factor Receptor Superfamily Member 18 Sales Market Share in Value by Application (2017-2028)
    Figure 37. Global Tumor Necrosis Factor Receptor Superfamily Member 18 Sales by Application (2017-2028) & (K Pcs)
    Figure 38. Global Tumor Necrosis Factor Receptor Superfamily Member 18 Sales Market Share in Volume by Application (2017-2028)
    Figure 39. Global Tumor Necrosis Factor Receptor Superfamily Member 18 Price by Application (2017-2028) & (USD/Pcs)
    Figure 40. United States Tumor Necrosis Factor Receptor Superfamily Member 18 Market Share by Application in 2022 & 2028
    Figure 41. United States Tumor Necrosis Factor Receptor Superfamily Member 18 Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 42. United States Tumor Necrosis Factor Receptor Superfamily Member 18 Sales Market Share in Value by Application (2017-2028)
    Figure 43. United States Tumor Necrosis Factor Receptor Superfamily Member 18 Sales by Application (2017-2028) & (K Pcs)
    Figure 44. United States Tumor Necrosis Factor Receptor Superfamily Member 18 Sales Market Share in Volume by Application (2017-2028)
    Figure 45. United States Tumor Necrosis Factor Receptor Superfamily Member 18 Price by Application (2017-2028) & (USD/Pcs)
    Figure 46. North America Tumor Necrosis Factor Receptor Superfamily Member 18 Sales in Volume Growth Rate 2017-2028 (K Pcs)
    Figure 47. North America Tumor Necrosis Factor Receptor Superfamily Member 18 Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 48. U.S. Tumor Necrosis Factor Receptor Superfamily Member 18 Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 49. Canada Tumor Necrosis Factor Receptor Superfamily Member 18 Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 50. Europe Tumor Necrosis Factor Receptor Superfamily Member 18 Sales in Volume Growth Rate 2017-2028 (K Pcs)
    Figure 51. Europe Tumor Necrosis Factor Receptor Superfamily Member 18 Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 52. Germany Tumor Necrosis Factor Receptor Superfamily Member 18 Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 53. France Tumor Necrosis Factor Receptor Superfamily Member 18 Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 54. U.K. Tumor Necrosis Factor Receptor Superfamily Member 18 Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 55. Italy Tumor Necrosis Factor Receptor Superfamily Member 18 Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 56. Russia Tumor Necrosis Factor Receptor Superfamily Member 18 Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 57. Asia-Pacific Tumor Necrosis Factor Receptor Superfamily Member 18 Sales in Volume Growth Rate 2017-2028 (K Pcs)
    Figure 58. Asia-Pacific Tumor Necrosis Factor Receptor Superfamily Member 18 Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 59. China Tumor Necrosis Factor Receptor Superfamily Member 18 Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 60. Japan Tumor Necrosis Factor Receptor Superfamily Member 18 Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 61. South Korea Tumor Necrosis Factor Receptor Superfamily Member 18 Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 62. India Tumor Necrosis Factor Receptor Superfamily Member 18 Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 63. Australia Tumor Necrosis Factor Receptor Superfamily Member 18 Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 64. Taiwan Tumor Necrosis Factor Receptor Superfamily Member 18 Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 65. Indonesia Tumor Necrosis Factor Receptor Superfamily Member 18 Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 66. Thailand Tumor Necrosis Factor Receptor Superfamily Member 18 Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 67. Malaysia Tumor Necrosis Factor Receptor Superfamily Member 18 Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 68. Philippines Tumor Necrosis Factor Receptor Superfamily Member 18 Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 69. Latin America Tumor Necrosis Factor Receptor Superfamily Member 18 Sales in Volume Growth Rate 2017-2028 (K Pcs)
    Figure 70. Latin America Tumor Necrosis Factor Receptor Superfamily Member 18 Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 71. Mexico Tumor Necrosis Factor Receptor Superfamily Member 18 Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 72. Brazil Tumor Necrosis Factor Receptor Superfamily Member 18 Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 73. Argentina Tumor Necrosis Factor Receptor Superfamily Member 18 Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 74. Middle East & Africa Tumor Necrosis Factor Receptor Superfamily Member 18 Sales in Volume Growth Rate 2017-2028 (K Pcs)
    Figure 75. Middle East & Africa Tumor Necrosis Factor Receptor Superfamily Member 18 Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 76. Turkey Tumor Necrosis Factor Receptor Superfamily Member 18 Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 77. Saudi Arabia Tumor Necrosis Factor Receptor Superfamily Member 18 Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 78. U.A.E Tumor Necrosis Factor Receptor Superfamily Member 18 Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 79. Tumor Necrosis Factor Receptor Superfamily Member 18 Value Chain
    Figure 80. Tumor Necrosis Factor Receptor Superfamily Member 18 Production Process
    Figure 81. Channels of Distribution
    Figure 82. Distributors Profiles
    Figure 83. Bottom-up and Top-down Approaches for This Report
    Figure 84. Data Triangulation
    Figure 85. Key Executives Interviewed